Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - CTI BIOPHARMA CORP | Financial_Report.xls |
EX-32 - EX-32 - CTI BIOPHARMA CORP | ctic-ex32_2014123111.htm |
EX-12.1 - EX-12.1 - CTI BIOPHARMA CORP | ctic-ex121_201412316.htm |
EX-23.1 - EX-23.1 - CTI BIOPHARMA CORP | ctic-ex231_201412318.htm |
EX-31.1 - EX-31.1 - CTI BIOPHARMA CORP | ctic-ex311_2014123110.htm |
EX-10.6 - EX-10.6 - CTI BIOPHARMA CORP | ctic-ex106_20141231464.htm |
EX-10.4 - EX-10.4 - CTI BIOPHARMA CORP | ctic-ex104_20141231463.htm |
EX-10.14 - EX-10.14 - CTI BIOPHARMA CORP | ctic-ex1014_201412311331.htm |
EX-10.16 - EX-10.16 - CTI BIOPHARMA CORP | ctic-ex1016_201412312020.htm |
EX-10.48 - EX-10.48 - CTI BIOPHARMA CORP | ctic-ex1048_201412311721.htm |
EX-10.15 - EX-10.15 - CTI BIOPHARMA CORP | ctic-ex1015_201412311332.htm |
10-K - 10-K - CTI BIOPHARMA CORP | ctic-10k_20141231.htm |
EX-31.2 - EX-31.2 - CTI BIOPHARMA CORP | ctic-ex312_201412317.htm |
Exhibit 21.1
Subsidiaries of CTI BioPharma Corp.
Aequus Biopharma, Inc., a Washington corporation, Systems Medicine, LLC, a Delaware limited liability company, and CTI Life Sciences Ltd., a U.K. limited company.
The above paragraph includes all subsidiaries of CTI BioPharma Corp.